TY - JOUR T1 - High-dose chemotherapy plus autologous stem-cell transplantation as consolidation therapy in patients with relapsed multiple myeloma after previous autologous stem-cell transplantation (NCRI Myeloma X Relapse [Intensive trial]): a randomised, open-label, phase 3 trial JO - The Lancet Oncology PY - 2014/01/01 AU - Cook G AU - Parrish C AU - O'Connor S AU - Williams C AU - Brown JM AU - Cairns DA AU - Fletcher M AU - Chalmers A AU - Cavenagh J AU - Snowden JA AU - Ashcroft AJ et al ED - DO - DOI: 10.1016/S1470-2045(14)70245-1 Y2 - 2025/06/23 ER -